Here's to a safe and happy New Year!
Register now for a live webinar by Berkley Life Sciences and the law firm of Bowman and Brooke LLP titled “2019 Life Science Litigation Recap & What’s Coming in 2020.”
When: Tuesday, February 25th @ 2:00 p.m. (EST) (webinar will be recorded)
Kim Schmid, Executive Managing Partner at Bowman and Brooke, Jennifer Bullard, Partner at Bowman and Brooke, and Cindy Khin, Life Sciences Casualty Resolution Director at Berkley Life Sciences, discuss what is coming in 2020, and review what happened in 2019:
- Mass Tort Litigation/Litigation Trends
- Government Enforcement Acts
- Pharmaceutical Updates
- Third Party Funding
- Legal and Regulatory Changes
- Social Inflation
Register now to learn about these newsworthy topics from three of the life science industry's leading experts.
Berkley Life Sciences' Life Sciences Resolution Director, Cindy Khin is presenting on July 25th at the American Conference Institute's "Women Leaders in Life Sciences Law". Cindy will participate in a panel discussion titled "Understanding How the Evolution of #MeToo is Influencing Diversity and Inclusion in the Workplace".
The conference will be held in Boston, MA at the Omni Parker House.
Berkley Life Sciences and the law firm of Bowman and Brooke LLP would like to invite you to a live webinar titled “2018 Life Science Litigation Recap & What’s Coming in 2019.”
Kim Schmid, Firm Vice Chair and Executive Managing Partner at Bowman and Brooke, and Cindy Khin, Life Sciences Casualty Resolution Director at Berkley Life Sciences, will look back on 2018 and examine litigation trends as well as review significant jury verdicts, settlements and noteworthy rulings. They will preview 2019 with an overview of FDA developments, litigation trends and forecasts for 2019.
Click here to learn about these newsworthy topics from two of the life science industry's leading experts.
Ewing, NJ, October 18, 2018 – Berkley Life Sciences, a Berkley Company
We are very pleased to announce the appointment of Emily J. Urban as president of Berkley Life Sciences, a Berkley Company. Ms. Urban succeeds Jill E. Wadlund, who has been named non-executive vice-chairman of Berkley Life Sciences. The appointments are effective immediately.
Emily and Jill have worked side by side to build a unique organization to serve the life science industry, and to create a special, collaborative relationship with you, our customers. Commenting on this transition, Jill noted: “Emily is the best and natural choice to lead Berkley Life Sciences as we continue to grow and prosper. Change is very healthy for any company, and I am confident that Berkley Life Sciences will reach new heights of achievement under Emily’s leadership.”
During an all-employee town hall held earlier today, Emily expressed her thanks to W. Robert Berkley, Jr., president and chief executive officer of W. R. Berkley Corporation, and William M. Rohde, Jr., Executive Vice President of W. R. Berkley Corporation, for the opportunity to continue the mission that she and Jill began over 11 years ago. Emily also shared an emotional “thank you” to Jill for all they have learned together over the years, and wished her all the best in her transition.
To our valued customers, Emily expresses a message of appreciation for all of their support since Berkley Life Sciences’ inception in May, 2007. “Without you, we would not have reached this level of success in this relatively short period of time. I look forward to working with all of our customers to achieve further success, and commit that Berkley Life Sciences will provide the innovation and service necessary to meet our customers’ needs in a dynamic marketplace.”
Emily looks forward to speaking with each one of you personally in the near future. In the interim, if you have any questions, please contact your territory manager.
Please click here to read the press release issued this morning by W.R. Berkley Corporation.
Berkley Life Sciences and the law firm of Greenberg Traurig presents “Beyond The Bleeding Edge: Emerging Litigation Threats Facing the Medical Device Industry and Strategies and Tactics for Changing the Paradigm” Webinar
With the recent release of the Netflix Original, The Bleeding Edge, there has been a surge, both in the news and on social media, in criticism of the medical device industry and FDA’s premarket review process.
This program is designed to assist clients in combating negative perceptions in the media, as well as the potential for courtroom bias, by highlighting how clients can manage the impact of media- and plaintiff-imposed narratives
Register now to learn about this newsworthy topic from two experts in the life science industry.
Berkley Life Sciences and the law firm of Bowman and Brooke LLP would like to invite you to a live webinar titled “2017 Life Science Litigation Recap & What’s Coming in 2018.”
Kim Schmid, Firm Vice Chair and Executive Managing Partner at Bowman and Brooke, and Cindy Khin, Life Sciences Casualty Resolution Director at Berkley Life Sciences, will look back on 2017 and examine litigation trends as well as review significant jury verdicts, settlements and noteworthy rulings.
Click here to register and learn about these newsworthy topics from two of the life science industry's leading experts.
Berkley Life Sciences is pleased to announce Hedy Linette Ranieri, Vice President and Chief Resolution Officer will be a speaker at the 2017 Litigation Management Institute (LMI) program. As a faculty member at LMI, Ms. Ranieri along with Nelson Tavares, from W. R. Berkley Corporation will be discussing the topic of “Evaluation and Assessment: Impact Reporting and Reserving”. This event will be held on October 19th - 22nd at the Loyola University Chicago - School of Law in Chicago, Illinois
Hedy Linette Ranieri has over 34 years of experience in the property and casualty insurance industry. Prior to joining Berkley Life Sciences, Ms. Ranieri held positions with several insurance carriers including Chubb, where she managed a team of Life Science Examiners. Ms. Ranieri also has held positions with Aetna Casualty & Surety and Hanover Insurance Company. Prior to joining Berkley Life Sciences she was a Director with Everest National Insurance Company. At Everest, Ms. Ranieri managed Medical Malpractice and Environmental Program claims on a national basis. Her diverse experience includes supervising and managing complex commercial toxic tort, environmental, asbestos, property, casualty, employment practices, directors and officers, personal lines and automobile claims. Ms. Ranieri is a member of the American Society of Law, Medicine & Ethics; Defense Research Institute; and the Counsel on Litigation Management. She is a graduate of East Carolina University where she received a Bachelor of Science degree in Environmental Health.
Berkley Life Sciences ranks #354 in 2017 Fortune 500, view the PDF here.
Berkley Life Sciences is proud to congratulate Tricia Danks, Resolution Specialist, on the achievement of being named a recipient of the 2017 RISE Award.